You have 9 free searches left this month | for more free features.

Berzosertib

Showing 1 - 15 of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Berzosertib
  • Sacituzumab Govitecan
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Other Cancer Trial in Budapest ([14C]M6620, M6620, Topotecan)

Recruiting
  • Other Cancer
  • Budapest, Hungary
  • +1 more
Jun 22, 2022

Leiomyosarcoma, Adult Trial in France (Association of berzosertib with gemcitabine, Gemcitabine)

Recruiting
  • Leiomyosarcoma, Adult
  • Bordeaux, France
  • +5 more
Jul 27, 2022

Metastatic Lung Neuroendocrine Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in

Active, not recruiting
  • Metastatic Lung Neuroendocrine Neoplasm
  • +6 more
  • Berzosertib
  • +3 more
  • Duarte, California
  • +8 more
Jul 16, 2022

Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)

Active, not recruiting
  • Small-cell Lung Cancer
  • Santa Rosa, California
  • +47 more
Jun 24, 2022

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting
  • Metastatic Fallopian Tube Carcinoma
  • +11 more
  • Berzosertib
  • +4 more
  • Phoenix, Arizona
  • +13 more
Dec 2, 2022

Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,

Recruiting
  • Lung Non-Small Cell Squamous Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Berzosertib
  • +6 more
  • Los Angeles, California
  • +34 more
Jan 20, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Berzosertib
  • +3 more
  • Duarte, California
  • +22 more
Jan 3, 2023

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Berzosertib
  • +3 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +7 more
  • Berzosertib
  • +4 more
  • Duarte, California
  • +30 more
Jan 7, 2023

Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)

Completed
  • Neoplasms
  • Veliparib + VX-970 + Cisplatin
  • Bethesda, Maryland
  • +2 more
Jan 14, 2022

Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Metastatic Ureter Urothelial

Active, not recruiting
  • Metastatic Bladder Urothelial Carcinoma
  • +3 more
  • Berzosertib
  • +2 more
  • Phoenix, Arizona
  • +38 more
Jul 13, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States

Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Berzosertib
  • Irinotecan Hydrochloride
  • Los Angeles, California
  • +22 more
Jun 28, 2022